Drugs / JNJ 28431754 300 mg/placebo
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01177163 | May 2008 → Mar 2009 | type 2 diabetes mellitus | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JNJ 28431754 300 mg/placebo | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01177163 ↗ |
| Route | Oral | “oral (taken by mouth) doses of JNJ 28431754 taken once or twice daily” NCT01177163 ↗ |